Bayer's asundexian reduces stroke risk by 26% in phase III trial

Go back to Bayer's asundexian reduces stroke risk by 26% in phase III trial
Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) Delayed: 14.37 +0.25 (1.77%)
Previous Close $14.12    52 Week High $135.54 
Open $14.34    52 Week Low $94.36 
Day High $14.41    P/E N/A 
Day Low $14.28    EPS $0.00 
Volume 441,275       

Bayer AG (AMEX: BAYZF) Delayed: 54.61 --0 (-0%)
Previous Close $54.61    52 Week High $135.00 
Open $54.61    52 Week Low $94.95 
Day High $54.61    P/E N/A 
Day Low $54.61    EPS $0.00 
Volume 748